Regenerative Medical Solutions
Chicago, US · Founded 2011 · Delaware corporation
RMS develops stem cell therapies to regenerate insulin-producing pancreatic beta cells as a potential cure for Type 1 and Type 2 diabetes. The company uses induced pluripotent stem cell (iPSC) technology to create scalable, non-embryonic solutions that aim to restore natural insulin function.
Founders & leadership
Regenerative Medical Solutions was founded in 2011 by Jon S. Odorico, MD, FACS and Dr. Jon Odorico.
JS
Jon S. Odorico, MD, FACSCo-founder
DJ
Dr. Jon OdoricoScientific Founder
AD
Anthony D. KoltoninPresident and CEO
GT
Guy TagliaviainChief Operating Officer
TP
Thomas P. JoyceinVice President
Board
GG
Gary GormanFounding Partner
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 4 rounds · 2014–2023
▶$5MraisedAug 2023 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony D. KoltonExecutive Officer, Director
- Amount sold
- $5M
- Minimum investment
- $25K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$181KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$181KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony D. KoltonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $181K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$375KraisedNov 2014 · 1 investors · BiotechnologyRule 506(b)
▶$375KraisedNov 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas JoyceExecutive Officer
- Anthony D. KoltonExecutive Officer, Director
- Guy TagliaviaExecutive Officer
- Offering amount
- $3M
- Amount sold
- $375K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$595KraisedJul 2014 · 9 investors · BiotechnologyRule 506(b)
▶$595KraisedJul 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony D. KoltonExecutive Officer, Director
- Guy TagliaviaExecutive Officer
- Gary GormanDirector
- Jon S. Odorico, MD, FACSDirector
- Thomas P. JoyceExecutive Officer
- Offering amount
- $1M
- Amount sold
- $595K
- Minimum investment
- $25K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Diabetes58 shared keywordsA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
Intechopen55 shared keywordsIntechOpen is an open access publisher of books and open science journals covering science, technology, and medicine, serving academics and researchers across interdisciplinary fields. It also operates a book series model with editorial-board-led topics and a custom manuscript submission and peer review platform.
Companies competing with Regenerative Medical Solutions for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $275K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $259.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $222K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Regenerative Medical Solutions do?
- RMS develops stem cell therapies to regenerate insulin-producing pancreatic beta cells as a potential cure for Type 1 and Type 2 diabetes. The company uses induced pluripotent stem cell (iPSC) technology to create scalable, non-embryonic solutions that aim to restore natural insulin function.
- Who founded Regenerative Medical Solutions?
- Regenerative Medical Solutions was founded by Jon S. Odorico, MD, FACS, Dr. Jon Odorico in 2011.
- How much funding has Regenerative Medical Solutions raised?
- Regenerative Medical Solutions has disclosed $6.2M raised across 4 rounds.
- Where is Regenerative Medical Solutions headquartered?
- Regenerative Medical Solutions is headquartered in Chicago, US.